|
Income Taxes - Additional Information (Detail) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Sep. 30, 2014
|
Sep. 30, 2013
|
|
| Income Taxes [Line Items] | ||
| Deferred Tax Assets, Operating Loss Carryforwards, Domestic | $ 6,230,000 | $ 3,486,000 |
| Research and experimentation credit carryforwards | 63,368 | 32,559 |
| Deferred tax assets, operating loss carryforwards, state and local | 5,271,000 | 2,800,000 |
| Valuation allowance, deferred tax asset, change in amount | 2,202,000 | 589,000 |
|
Expire In 2023
|
||
| Income Taxes [Line Items] | ||
| Research and experimentation credit carryforwards | 19,000 | 10,000 |
|
Expire in 2029
|
||
| Income Taxes [Line Items] | ||
| Research and experimentation credit carryforwards | $ 44,112 | $ 32,559 |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|